Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis

Impact Factor: 4.9 (2023). 5-Year Impact Factor: 5.5 (2023). Se publicó como preprint en: https://www.preprints.org/manuscript/202402.0587/v1

Saved in:
Bibliographic Details
Main Authors: Magi, María S., de Lafuente, Yanina, Quarta, Eride, Palena, María C., Ardiles, Perla del R., Páez, Paulina L., Sonvico, Fabio, Buttini, Francesca, Jimenez Kairuz, Alvaro F.
Other Authors: https://orcid.org/0009-0007-8482-4144
Format: info:eu-repo/semantics/publishedVersion biblioteca
Language:eng
Published: Academic Editor: Vivek Verma 2024-03-22
Subjects:Inhalable vancomycin, Cystic fibrosis, Polyelectrolyte–drug complex, Hyaluronic acid, Pulmonary infection,
Online Access:http://hdl.handle.net/11086/552768
https://www.mdpi.com/1999-4923/16/4/436
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054002/
http://doi.org/10.3390/pharmaceutics16040436
Tags: Add Tag
No Tags, Be the first to tag this record!